COVID-19 in patients with gout on colchicine

Volume: 41, Issue: 8, Pages: 1503 - 1507
Published: Jun 5, 2021
Abstract
Current data demonstrated that severe cases of coronavirus-disease-19 (COVID-19) require treatment with antiviral therapy, dexamethasone, supportive care, as well as some anti-rheumatic drugs, among them, cytokine inhibitors and colchicine. Colchicine is an anti-inflammatory drug that is being used in rheumatology for many years to treat mostly gout, calcium pyrophosphate deposition disease, and Familial Mediterranean Fever. Here, we present for...
Paper Details
Title
COVID-19 in patients with gout on colchicine
Published Date
Jun 5, 2021
Volume
41
Issue
8
Pages
1503 - 1507
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.